Surviving Lymphoma: Secondary Cancers

Secondary cancers are cancers that develop as a result of chemotherapy and/or radiotherapy. These cancers are usually unrelated to the first disease a patient suffered from. Rather, they are a long-term side effect of the treatment used to combat the original cancer.

These side-effects can occur months or years after a patient enters remission. The use of strong chemotherapy agents like etoposide, high doses of radiation, or combination chemo and radiation therapy all increase a patient's risk of developing a secondary cancer.

Due to this possibility, cancer survivors are monitored closely by their doctors. That way, if a secondary cancer does arise, it will be caught early when it is treatable.

Hodgkin's Lymphoma

For Hodkgin's Lymphoma, the most common secondary cancers are:

  • Stomach cancer
  • Lung cancer
  • Colorectal cancer
  • Thyroid cancer
  • Breast cancer
  • Bone cancer
  • Leukemia
  • Non-Hodgkin Lymphoma

The chance for developing a secondary cancer after 20 years of remission is 10%. This risk increases to 26% after 30 years. Patients who were younger than 21 years of age during their treatment have a higher incidence of secondary cancers, and that risk increases if both chemotherapy and radiation were used.

Non-Hodgkin's Lymphoma (NHL)

The most common secondary cancers after treatment for Non-Hodgkin's Lymphomas are:

  • Leukemia
  • Other Non-Hodgkin's Lymphomas

The incidence rates for secondary cancers are usually lower when compared to Hodgkin's patients. However, these statistics change based on the type of NHL and the treatment used.

Photo: Pexels

More Articles

More Articles

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

The Follicular Lymphoma International Prognostic Index, or FLIPI, is a standardized guide to help oncological diagnosticians accurately calculate...

Diffuse large B cell lymphoma prognosis is contingent upon several factors, and can be determined by using a well-...

The term 'metastatic lymphoma' does not refer to a diagnosis. Unlike many of the subtypes of lymphoma we have...

Diagnosing lymphoma is one of the more difficult diagnoses to make in cancer medicine, and contrary to perception, diagnosing lymphoma is not made...

Burkitt's lymphoma is an aggressive B-cell lymphoma that is common in children...

Treatment for Non-Hodgkin’s Lymphomas (NHL) differs from patient to patient. The regimen used depends on the type of...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

Follicular lymphoma is classified as a Non-Hodgkin's Lymphoma. It is an indolent (slow-growing) cancer that affects...

Aggressive Non-Hodgkin’s Lymphomas (NHLs) are fast growing cancers (as opposed to indolent cancers). They involve...

Lymphoma is not difficult to diagnose once a patient and doctor begin to look for signs of cancer. However, Lymphoma–especially...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

The lymphatic system, or lymph system, defends the body from foreign invasion by disease causing agents such as viruses, bacteria, or fungi. The...

Lymphoma is a cancer of the lymphatic system, causing B-cell or...